
PB Fintech reported a 92% increase in its consolidated profit after tax (PAT) to INR 71.54 Cr in the third quarter of the fiscal year 2024-25 (Q3 FY25).
With the rise in its share price, the company’s market capitalisation reached INR 78,041 Cr at 10:30 AM
On a quarter-on-quarter basis, PB Fintech's net profit climbed over 40% from INR 50.98 Cr
Shares of insurtech major Policybazaar’s parent PB Fintech jumped over 3% to INR 1706.95 during the intraday session on the the BSE today (January 31) after reporting a 92% increase in its consolidated profit after tax (PAT) to INR 71.54 Cr in the third quarter of the fiscal year 2024-25 (Q3 FY25).
With the rise in its share price, the company’s market capitalisation reached INR 78,041 Cr with over 15 Lakh shares traded hands by 10:30 AM.
At the time of writing, the stock shed some gains and was trading 2.68% up at INR 1696.20 apiece on BSE.
On a quarter-on-quarter basis, PB Fintech’s net profit climbed over 40% from INR 50.98 Cr.
It is pertinent to note that this was the fifth consecutive profitable quarter for PB Fintech.
The company clocked an EBITDA profit of INR 28 Cr during the quarter under review against an EBITDA loss of INR 25 Cr in Q3 FY24.
Operating revenue zoomed 48% to INR 1,291.62 Cr in Q3 FY25 from INR 870.89 Cr in the corresponding quarter last year. Sequentially, it rose nearly 11% from INR 1,167.23 Cr.
The company primarily generates revenue from its insurance business PolicyBazaar and credit services business Paisabazaar.
While revenue from the insurance business jumped 45% year-on-year to INR 651 Cr in Q3 FY25, revenue from the credit business declined 18% YoY to INR 119 Cr due to a slowdown in demand
Earlier this month, PB Fintech entered the healthcare segment through its new subsidiary, PB Healthcare Services Private Limited. Last year, PB Fintech chairman and group CEO Yashish Dahiya said that the company is considering making a foray into the healthcare space and would make a one-time investment of $100 Mn to acquire a 30% stake in a new healthcare company.